No Data
Citi: Maintains the rating of HYGEIA HEALTH (06078) and JXR (01951) as "Outperform" and also lowers the Target Price for both.
Lyon has lowered HYGEIA HEALTH's net profit forecast for the next two years by 2% to 8%.
Four months after the repurchase, is a rebound opportunity approaching? Could the 2024 annual report be the key to the sustained rise in HYGEIA HEALTH (06078) stock price?
Considering the company's fundamentals, the recent decline in stock price mainly reflects the market's concerns about the company's slower expansion and recent profit performance. However, on the other hand, HYGEIA HEALTH is expected to benefit from the long-term opportunities brought about by market consolidation, which may become an important factor for its subsequent valuation recovery.
Returns At Hygeia Healthcare Holdings (HKG:6078) Appear To Be Weighed Down
[Brokerage Focus] BOCOM INTL indicates that private Medical Services are seeking steady progress while focusing on investment opportunities amid an aging population and supply-demand mismatch.
Jinwu Financial News | BOCOM INTL released research on the Medical Services sector of the private healthcare industry, indicating that the current focus on investing in the private healthcare services sector is mainly due to 1) valuations having dropped to historical lows, with a recovery in performance growth expected; 2) short-term impacts of reforms likely to gradually clear, while long-term support for the direction of private healthcare services remains unchanged; 3) demographic changes are a key long-term growth driver for the sector. The firm suggests that when selecting investment symbols in the private healthcare services sector, both short-term performance certainty and risks, as well as long-term growth capacity, should be considered while taking into account current valuation levels. The firm's preferred ranking among various specialties is: Traditional Chinese Medicine > Oncology > Ophthalmology > Dentistry >.
On January 23, HYGEIA HEALTH (06078) spent 1.6707 million Hong Kong dollars to repurchase 0.1338 million shares.
HYGEIA HEALTH (06078) announced that on January 23, 2025, it will spend 1.6707 million Hong Kong dollars to repurchase...
UBS Group: Maintains HYGEIA HEALTH (06078) "Buy" rating with a Target Price of 20 Hong Kong dollars.
UBS Group expects that HYGEIA HEALTH's adjusted earnings will have an average annual compound growth rate of 12% from 2023 to 2026.
Hygeia Healthcare Holdings (HKG:6078) Is Looking To Continue Growing Its Returns On Capital
